Cargando…

Advances in PET/CT Imaging for Breast Cancer Patients and Beyond

Detalles Bibliográficos
Autores principales:	Khalil, David, Lotfalla, Andrew, Girard, Antoine, Ha, Richard, Dercle, Laurent, Seban, Romain-David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861174/ https://www.ncbi.nlm.nih.gov/pubmed/36675588 http://dx.doi.org/10.3390/jcm12020651

Ejemplares similares

PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer
por: McGale, Jeremy, et al.
Publicado: (2023)

Advances in PET/CT Imaging for Breast Cancer
por: de Jong, Dorine, et al.
Publicado: (2023)

Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?
por: Seban, Romain-David, et al.
Publicado: (2021)

The Role of Cost-Effectiveness Analysis in Patient-Centered Cancer Care in the Era of Precision Medicine
por: Toscano, Fabrizio, et al.
Publicado: (2021)

Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer
por: Najid, Sophia, et al.
Publicado: (2023)

Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine
por: Seban, Romain-David, et al.
Publicado: (2021)

The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma
por: Girard, Antoine, et al.
Publicado: (2020)

Editorial: Breakthrough in Imaging-Guided Precision Medicine in Oncology
por: Shaw, Ashley, et al.
Publicado: (2022)

PET Imaging in Bladder Cancer: An Update and Future Direction
por: Zhang-Yin, Jules, et al.
Publicado: (2023)

Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma
por: Higgins, Hayley, et al.
Publicado: (2023)

Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT
por: Seban, Romain-David, et al.
Publicado: (2021)

Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy
por: Seban, Romain-David, et al.
Publicado: (2019)

(18)F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab
por: Seban, Romain-David, et al.
Publicado: (2021)

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab
por: Seban, Romain-David, et al.
Publicado: (2020)

Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging
por: Schiepers, Christiaan, et al.
Publicado: (2010)

Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on (18)F-FDG PET/CT: A Focus in Breast Cancer Care
por: Seban, Romain-David, et al.
Publicado: (2022)

Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy
por: Grambow-Velilla, Julia, et al.
Publicado: (2023)

Importance of measurement repeatability of semi-quantitative imaging through PET-CT and PET-MR imaging in oncology
por: Priola, Adriano Massimiliano, et al.
Publicado: (2019)

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [(18)F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors
por: Lopci, E., et al.
Publicado: (2022)

PET/CT in Prostate Cancer
por: Evangelista, Laura, et al.
Publicado: (2023)

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [(18)F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0
por: Lopci, E., et al.
Publicado: (2022)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

Fundamentals of Oncologic PET-CT Reporting
por: Bijan, Bijan, et al.
Publicado: (2013)

PET/CT and the solitary pulmonary nodule
por: Pinto, Erique Guedes, et al.
Publicado: (2020)

PET/CT and interstitial lung disease
por: Sawamura, Marcio Valente Yamada, et al.
Publicado: (2022)

New! F-18-based PET/CT for sodium-iodine-symporter-targeted imaging!
por: Verburg, Frederik A., et al.
Publicado: (2020)

New Trends and Advances in MRI and PET Hybrid Imaging in Diagnostics
por: Crimì, Filippo, et al.
Publicado: (2023)

Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer
por: Ming, Yue, et al.
Publicado: (2020)

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond
por: Hildebrandt, Malene Grubbe, et al.
Publicado: (2019)

The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection
por: Alavi, Abass, et al.
Publicado: (2021)

Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET
por: Koolen, B. B., et al.
Publicado: (2012)

PET/CT in the evaluation of pulmonary solitary nodule
por: Barbosa, Felipe de Galiza
Publicado: (2016)

Ga-DOTA PET/CT: the first-line functional imaging modality in the management of patients with neuroendocrine tumors
por: Mesquita, Cláudio Tinoco, et al.
Publicado: (2022)

(18)F-fluoride PET/CT in clinical practice
por: Ramos, Celso Darío
Publicado: (2015)

PET and PET/CT imaging of skeletal metastases
por: Cook, Gary J.R.
Publicado: (2010)

Hybrid imaging with PET/CT and PET/MR
por: Kjaer, Andreas
Publicado: (2014)

Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
por: Vercellino, Laetitia, et al.
Publicado: (2022)

Clinical molecular anatomic imaging: PET, PET/CT, and Spect/CT
por: Von Schulthess, Gustav K
Publicado: (2003)

PET/CT and breast cancer
por: Hegarty, C., et al.
Publicado: (2010)

Artefacts of PET/CT images
por: Pettinato, C, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_t8645nka1lvff76heiidua20ro